{"record_type":"pith_number_record","schema_url":"https://pith.science/schemas/pith-number/v1.json","pith_number":"pith:2024:3OBF7ZDUJVUZI6XTX4U7UNXH7B","short_pith_number":"pith:3OBF7ZDU","schema_version":"1.0","canonical_sha256":"db825fe4744d69947af3bf29fa36e7f869dbfafdeddcf77e57074d9699ecc331","source":{"kind":"arxiv","id":"2406.01650","version":1},"attestation_state":"computed","paper":{"title":"TAGMol: Target-Aware Gradient-guided Molecule Generation","license":"http://creativecommons.org/licenses/by/4.0/","headline":"","cross_cats":["cs.AI","cs.LG"],"primary_cat":"q-bio.BM","authors_text":"D. Subhalingam, Keshav Kolluru, Mrityunjay Singh, N. M. Anoop Krishnan, Saurabh Singal, Sayan Ranu, Shreshth Tuli, Vineeth Dorna","submitted_at":"2024-06-03T14:43:54Z","abstract_excerpt":"3D generative models have shown significant promise in structure-based drug design (SBDD), particularly in discovering ligands tailored to specific target binding sites. Existing algorithms often focus primarily on ligand-target binding, characterized by binding affinity. Moreover, models trained solely on target-ligand distribution may fall short in addressing the broader objectives of drug discovery, such as the development of novel ligands with desired properties like drug-likeness, and synthesizability, underscoring the multifaceted nature of the drug design process. To overcome these chal"},"verification_status":{"content_addressed":true,"pith_receipt":true,"author_attested":false,"weak_author_claims":0,"strong_author_claims":0,"externally_anchored":false,"storage_verified":false,"citation_signatures":0,"replication_records":0,"graph_snapshot":true,"references_resolved":false,"formal_links_present":false},"canonical_record":{"source":{"id":"2406.01650","kind":"arxiv","version":1},"metadata":{"license":"http://creativecommons.org/licenses/by/4.0/","primary_cat":"q-bio.BM","submitted_at":"2024-06-03T14:43:54Z","cross_cats_sorted":["cs.AI","cs.LG"],"title_canon_sha256":"492d4e9a6190f2ca8a90f0d74f7cc4005f7858508500d6798add5fa001259e7f","abstract_canon_sha256":"6a12a9681a839cc4bd4867e04451f1e09a9ab17d84e03f823263568eab5ca64f"},"schema_version":"1.0"},"receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-07-05T08:26:46.169571Z","signature_b64":"ATZeczYs79T9kc9lQEFEl5bup/iLSTFto1TAtb8/1uftAL1o/iKU+zkiqiquc8KoAUNaC2dgeb4389/OipzYAQ==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"db825fe4744d69947af3bf29fa36e7f869dbfafdeddcf77e57074d9699ecc331","last_reissued_at":"2026-07-05T08:26:46.169139Z","signature_status":"signed_v1","first_computed_at":"2026-07-05T08:26:46.169139Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"graph_snapshot":{"paper":{"title":"TAGMol: Target-Aware Gradient-guided Molecule Generation","license":"http://creativecommons.org/licenses/by/4.0/","headline":"","cross_cats":["cs.AI","cs.LG"],"primary_cat":"q-bio.BM","authors_text":"D. Subhalingam, Keshav Kolluru, Mrityunjay Singh, N. M. Anoop Krishnan, Saurabh Singal, Sayan Ranu, Shreshth Tuli, Vineeth Dorna","submitted_at":"2024-06-03T14:43:54Z","abstract_excerpt":"3D generative models have shown significant promise in structure-based drug design (SBDD), particularly in discovering ligands tailored to specific target binding sites. Existing algorithms often focus primarily on ligand-target binding, characterized by binding affinity. Moreover, models trained solely on target-ligand distribution may fall short in addressing the broader objectives of drug discovery, such as the development of novel ligands with desired properties like drug-likeness, and synthesizability, underscoring the multifaceted nature of the drug design process. To overcome these chal"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2406.01650","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"integrity":{"clean":true,"summary":{"advisory":0,"critical":0,"by_detector":{},"informational":0},"endpoint":"/pith/2406.01650/integrity.json","findings":[],"available":true,"detectors_run":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938"},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"aliases":[{"alias_kind":"arxiv","alias_value":"2406.01650","created_at":"2026-07-05T08:26:46.169193+00:00"},{"alias_kind":"arxiv_version","alias_value":"2406.01650v1","created_at":"2026-07-05T08:26:46.169193+00:00"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2406.01650","created_at":"2026-07-05T08:26:46.169193+00:00"},{"alias_kind":"pith_short_12","alias_value":"3OBF7ZDUJVUZ","created_at":"2026-07-05T08:26:46.169193+00:00"},{"alias_kind":"pith_short_16","alias_value":"3OBF7ZDUJVUZI6XT","created_at":"2026-07-05T08:26:46.169193+00:00"},{"alias_kind":"pith_short_8","alias_value":"3OBF7ZDU","created_at":"2026-07-05T08:26:46.169193+00:00"}],"events":[],"event_summary":{},"paper_claims":[],"inbound_citations":{"count":5,"internal_anchor_count":0,"sample":[{"citing_arxiv_id":"2606.01628","citing_title":"Demystifying Multimodal Biomolecular Co-design With Intrinsic Geodesic Coupling","ref_index":94,"is_internal_anchor":false},{"citing_arxiv_id":"2606.01220","citing_title":"Fine-Tuning Diffusion Models for Molecular Generation via Reinforcement Learning and Fast Sampling","ref_index":4,"is_internal_anchor":false},{"citing_arxiv_id":"2605.17693","citing_title":"Fine-tuning Pocket-Aware Diffusion Models via Denoising Policy Optimization","ref_index":2,"is_internal_anchor":false},{"citing_arxiv_id":"2605.12784","citing_title":"ToolMol: Evolutionary Agentic Framework for Multi-objective Drug Discovery","ref_index":6,"is_internal_anchor":false},{"citing_arxiv_id":"2605.12784","citing_title":"ToolMol: Evolutionary Agentic Framework for Multi-objective Drug Discovery","ref_index":6,"is_internal_anchor":false}]},"formal_canon":{"evidence_count":0,"sample":[],"anchors":[]},"links":{"html":"https://pith.science/pith/3OBF7ZDUJVUZI6XTX4U7UNXH7B","json":"https://pith.science/pith/3OBF7ZDUJVUZI6XTX4U7UNXH7B.json","graph_json":"https://pith.science/api/pith-number/3OBF7ZDUJVUZI6XTX4U7UNXH7B/graph.json","events_json":"https://pith.science/api/pith-number/3OBF7ZDUJVUZI6XTX4U7UNXH7B/events.json","paper":"https://pith.science/paper/3OBF7ZDU"},"agent_actions":{"view_html":"https://pith.science/pith/3OBF7ZDUJVUZI6XTX4U7UNXH7B","download_json":"https://pith.science/pith/3OBF7ZDUJVUZI6XTX4U7UNXH7B.json","view_paper":"https://pith.science/paper/3OBF7ZDU","resolve_alias":"https://pith.science/api/pith-number/resolve?arxiv=2406.01650&json=true","fetch_graph":"https://pith.science/api/pith-number/3OBF7ZDUJVUZI6XTX4U7UNXH7B/graph.json","fetch_events":"https://pith.science/api/pith-number/3OBF7ZDUJVUZI6XTX4U7UNXH7B/events.json","actions":{"anchor_timestamp":"https://pith.science/pith/3OBF7ZDUJVUZI6XTX4U7UNXH7B/action/timestamp_anchor","attest_storage":"https://pith.science/pith/3OBF7ZDUJVUZI6XTX4U7UNXH7B/action/storage_attestation","attest_author":"https://pith.science/pith/3OBF7ZDUJVUZI6XTX4U7UNXH7B/action/author_attestation","sign_citation":"https://pith.science/pith/3OBF7ZDUJVUZI6XTX4U7UNXH7B/action/citation_signature","submit_replication":"https://pith.science/pith/3OBF7ZDUJVUZI6XTX4U7UNXH7B/action/replication_record"}},"created_at":"2026-07-05T08:26:46.169193+00:00","updated_at":"2026-07-05T08:26:46.169193+00:00"}